Cargando…

Bayesian updating and sequential testing: overcoming inferential limitations of screening tests

BACKGROUND: Bayes’ theorem confers inherent limitations on the accuracy of screening tests as a function of disease prevalence. Herein, we establish a mathematical model to determine whether sequential testing with a single test overcomes the aforementioned Bayesian limitations and thus improves the...

Descripción completa

Detalles Bibliográficos
Autor principal: Balayla, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734062/
https://www.ncbi.nlm.nih.gov/pubmed/34991576
http://dx.doi.org/10.1186/s12911-021-01738-w
Descripción
Sumario:BACKGROUND: Bayes’ theorem confers inherent limitations on the accuracy of screening tests as a function of disease prevalence. Herein, we establish a mathematical model to determine whether sequential testing with a single test overcomes the aforementioned Bayesian limitations and thus improves the reliability of screening tests. METHODS: We use Bayes’ theorem to derive the positive predictive value equation, and apply the Bayesian updating method to obtain the equation for the positive predictive value (PPV) following repeated testing. We likewise derive the equation which determines the number of iterations of a positive test needed to obtain a desired positive predictive value, represented graphically by the tablecloth function. RESULTS: For a given PPV ([Formula: see text] ) approaching k, the number of positive test iterations needed given a prevalence of disease ([Formula: see text] ) is: [Formula: see text] where [Formula: see text] = number of testing iterations necessary to achieve [Formula: see text] , the desired positive predictive value, ln = the natural logarithm, a = sensitivity, b = specificity, [Formula: see text] = disease prevalence/pre-test probability and k = constant. CONCLUSIONS: Based on the aforementioned derivation, we provide reference tables for the number of test iterations needed to obtain a [Formula: see text] of 50, 75, 95 and 99% as a function of various levels of sensitivity, specificity and disease prevalence/pre-test probability. Clinical validation of these concepts needs to be obtained prior to its widespread application.